Your browser doesn't support javascript.
loading
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction.
Anastasiou, Olympia E; Yurdaydin, Cihan; Maasoumy, Benjamin; Hardtke, Svenja; Caruntu, Florin Alexandru; Curescu, Manuela G; Yalcin, Kendal; Akarca, Ulus S; Gürel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lüth, Stefan; Papatheodoridis, George V; Radu, Monica; Liebig, Stephanie; Bantel, Heike; Bremer, Birgit; Manns, Michael P; Cornberg, Markus; Wedemeyer, Heiner.
Affiliation
  • Anastasiou OE; Institute of Virology, Essen University Hospital and Medical Faculty of the University of Duisburg-Essen, Duisburg, Germany.
  • Yurdaydin C; Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey.
  • Maasoumy B; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Hardtke S; University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Caruntu FA; German Center for Infectious Disease Research (DZIF), HepNet Study-House, Hannover, Germany.
  • Curescu MG; National Institute for Infectious Diseases Prof. Dr. Matei Bals, Bucharest, Romania.
  • Yalcin K; Spitalul Clinic de Boli Infectioase, University of Medicine and Pharmacy Timisoara, Timisoara, România, Romania.
  • Akarca US; Dicle University Medical Faculty, Diyarbakir, Turkey.
  • Gürel S; Ege University Medical Faculty, Izmir, Turkey.
  • Zeuzem S; Uludag University Medical Faculty, Bursa, Turkey.
  • Erhardt A; Johann Wolfgang Goethe University Medical Center, Frankfurt/Main, Germany.
  • Lüth S; Heinrich Heine University, Düsseldorf, Germany.
  • Papatheodoridis GV; Center of Internal Medicine II, University Hospital Brandenburg, Brandenburg Medical School, Brandenburg, Germany.
  • Radu M; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Liebig S; National Institute for Infectious Diseases Prof. Dr. Matei Bals, Bucharest, Romania.
  • Bantel H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Bremer B; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Cornberg M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Wedemeyer H; German Center for Infectious Disease Research (DZIF), HepNet Study-House, Hannover, Germany.
J Viral Hepat ; 28(2): 410-419, 2021 02.
Article in En | MEDLINE | ID: mdl-33185325
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Hepatitis D / Hepatitis B Surface Antigens Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Viral Hepat Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Hepatitis D / Hepatitis B Surface Antigens Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Viral Hepat Year: 2021 Document type: Article